当前位置:首页 >财报库 > 中译版报告详情

赛默飞世尔科技公司2022年年度报告(中译版)(96页).pdf

上传人: 无*** 编号:129455 2023-06-13 96页 6.22MB

下载:

1、Annual Report 2022Our Mission is to enable our customers to make the world healthier,cleaner and saferbrighterfutureBuilding aAnalyti cal InstrumentsLaboratory Products&Bi opharma Servi cesSpeci alty Di agnosti csLi f e Sci ences Soluti ons$44.92BRevenue10%47%14%29%Our Mission is to enableour custom

2、ers to make the world heal thi er,cl eaner and saf er.Complementary SegmentsMarc N.CasperChairman,President and CEOreconciliation of these non-GAAP measures to comparable GAAP measures,see pages 6 and 7 of this annual report.Adjusted EPS and free cash flow are non-GAAP financial measures.For a To ou

3、rsharehol ders,cust omers and col l eagues As I reflect on 2022,I am proud of what we achieved.Our teams incredible dedication to our customers and our Mission enabled us to successfully navigate a dynamic environment,exceed our goals and deliver value for all of our stakeholders.I would like to tha

4、nk our more than 125,000 colleagues,whose passion for enabling our customers to make the world healthier,cleaner and safer fuels our success.And thank you to our customers and shareholders for your continued confidence in us as a partner in building a brighter future for all.We measure our success i

5、n a number of ways not only by our financial results,but also by being the strongest partner for our customers,by providing an excellent work experience for our colleagues,by creating value for our shareholders and by making a positive impact on society.By all of these measures,it was another except

6、ional year for Thermo Fisher Scientific.Outstandi ng fi nanci al resul tsStarting with our financials,we continued our long track record of outstanding performance.In 2022,we grew our revenue by 15 percent to$44.92 billion,delivered strong earnings results consisting of GAAP diluted earnings per sha

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据Thermo Fisher Scientific的2022年年报,主要内容如下: 1. 财务业绩:2022年,公司收入增长15%,达到449.2亿美元,GAAP稀释每股收益为17.63美元,调整后每股收益为23.24美元,自由现金流为69.4亿美元。 2. 创新产品:公司投资15亿美元于研发,推出多项新产品,如Orbitrap Ascend Tribrid质谱仪、TRACE 1600系列气相色谱仪、Glacios 2 Cryo-TEM透射电子显微镜等,以支持客户在多个领域的科研工作。 3. 市场拓展:公司继续扩大在增长迅速和新兴市场的业务,如在中国杭州开设新的生物制药制造设施,在韩国仁川开设生物工艺供应中心,以满足亚太地区客户的需求。 4. 客户服务:公司通过并购,如收购PPD公司,加强制药服务业务,帮助客户更快、更可靠、更经济地开发新药。 5. 环境与社会责任:公司继续推进环境可持续性计划,减少碳排放,支持STEM教育项目,并提前一年实现招聘500名来自历史黑人大学及学院的毕业生目标。 6. 未来展望:公司拥有经验丰富的管理团队、强大的业务系统以及明确的使命,为2023年及以后的持续增长和成功奠定了基础。
2022年Thermo Fisher营收增长15%,达到449.2亿美元,这一增长背后的主要因素是什么? Thermo Fisher在2022年进行了哪些创新,以帮助客户解决全球性挑战? Thermo Fisher如何通过支持社区和环保行动,为社会做出积极贡献?
客服
商务合作
小程序
服务号
折叠